Evidence mapPaperPMID 38277115Full record

ReviewAnnals of nuclear medicine2024

Role of PET/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review.

Shashi B Singh, Sambhawana Bhandari, Sadikshya Bhandari, Samikshya Bhandari, Rajshree Singh, William Y Raynor, Soren Hess, Thomas J Werner, Abass Alavi, Mona-Elisabeth Revheim

Abstract readReview
In one paragraph

Review in Annals of nuclear medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Usefulness ofClinical rheumatology · 2026
    Article
  2. Review
  3. European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Rheumatoid Arthritis: Biomarkers and the Latest Breakthroughs.International journal of molecular sciences · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Rheumatology advances in practice · 2025
    Article
  16. Role of Total Body PET/CT in Inflammatory Disorders.Seminars in nuclear medicine · 2025
    Review
  17. Emerging Landscape ofACS pharmacology & translational science · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shashi B Singh *Department of Radiology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Sambhawana Bhandari *Department of Medicine, Division of Rheumatology, Washington University in St Louis, St Louis, MO, USA.
Sadikshya BhandariDanbury Hospital/Nuvance Health, Danbury, CT, USA.
Samikshya BhandariNepal Medical College Teaching Hospital, Attarkhel, Kathmandu, Nepal.
Rajshree SinghMercy Catholic Medical Center, Darby, PA, 19023, USA.
William Y RaynorDepartment of Radiology, Rutgers Robert Wood Johnson Medical School, 1 Robert Wood Johnson Place, MEB#404, New Brunswick, NJ, 08901, USA.
Soren HessDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Thomas J WernerDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, 19104, USA.
Abass AlaviDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, 19104, USA.
Mona-Elisabeth RevheimThe Intervention Center, Division of Technology and Innovation, Oslo University Hospital, Rikshospitalet, Nydalen, Post Box 4950, 0424, Oslo, Norway. m.e.rootwelt-revheim@medisin.uio.no.ORCID http://orcid.org/0000-0003-3300-7420

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid Arthritis (RA) is a systemic inflammatory disorder that commonly presents with polyarthritis but can have multisystemic involvement and complications, leading to increased morbidity and mortality. The diagnosis of RA continues to be challenging due to its varied clinical presentations. In this review article, we aim to determine the potential of PET/CT to assist in the diagnosis of RA and its complications, evaluate the therapeutic response to treatment, and predict RA remission. PET/CT has increasingly been used in the last decade to diagnose, monitor treatment response, predict remissions, and diagnose subclinical complications in RA. PET imaging with [

Indexed as

Arthritis, RheumatoidPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18HumansPositron-Emission TomographyRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals[18F]-fluorodeoxyglucose ([18F]-FDG)[18F]-sodium fluoride ([18F]-NaF)DiagnosisFibroblast activation protein inhibitor (FAPI)MonitoringPositron emission tomography/computed tomography (PET/CT)Rheumatoid arthritis (RA)

Identifiers

PMID38277115
PMCPMC10884090

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.